(Q36641822)

English

Anti-tumour effects and pharmacokinetic profile of 17-(5'-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesis

scientific article published on July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Anti-tumour effects and pharmacokinetic profile of 17-(5'-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesis (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

I P Nnane

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

B J Long

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Y Z Ling

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

D N Grigoryev

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A M Brodie

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

83

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

74-82

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Protein measurement with the Folin phenol reagent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

Effects of new 17alpha-hydroxylase/C(17,20)-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

Inhibitors of 17alpha-hydroxylase/17,20-lyase (CYP17): potential agents for the treatment of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

The role of PSA in the radiotherapy of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

Role of dihydrotestosterone in androgen action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

Hormonal therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

30 September 2017

The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

28 June 2018

Inhibition of testicular 17 alpha-hydroxylase and 17,20-lyase but not 3 beta-hydroxysteroid dehydrogenase-isomerase or 17 beta-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

28 June 2018

17 beta-(cyclopropylamino)-androst-5-en-3 beta-ol, a selective mechanism-based inhibitor of cytochrome P450(17 alpha) (steroid 17 alpha-hydroxylase/C17-20 lyase).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

28 June 2018

4-pregnene-3-one-20β-carboxaldehyde: A potent inhibitor of 17α-hydroxylase/C17,20-lyase and of 5α-reductase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

28 June 2018

Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

20 September 2018

Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374539

20 September 2018

Inhibitory effect and interaction of stanozolol with pig testicular cytochrome P-450 (17 alpha-hydroxylase/C17,20-lyase)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of androgen synthesis by 22-hydroximino-23,24-bisnor-4-cholen-3-one

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17 alpha-hydroxylase/C17,20-lyase

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SOME ASPECTS OF RELATION OF STRUCTURE OF STEROIDS TO THEIR PROSTATE--STIMULATING EFFECTS

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketoconazole Therapy in Advanced Prostatic Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10883671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.2000.1136

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36641822&oldid=2199129455"